rs149798652

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_021629.4(GNB4):​c.186T>C​(p.His62His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 1,605,316 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0019 ( 13 hom. )

Consequence

GNB4
NM_021629.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.154

Publications

1 publications found
Variant links:
Genes affected
GNB4 (HGNC:20731): (G protein subunit beta 4) Heterotrimeric guanine nucleotide-binding proteins (G proteins), which integrate signals between receptors and effector proteins, are composed of an alpha, a beta, and a gamma subunit. These subunits are encoded by families of related genes. This gene encodes a beta subunit. Beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. [provided by RefSeq, Jul 2008]
GNB4 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate F
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 3-179419416-A-G is Benign according to our data. Variant chr3-179419416-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 414884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.154 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00152 (232/152352) while in subpopulation NFE AF = 0.00276 (188/68020). AF 95% confidence interval is 0.00244. There are 0 homozygotes in GnomAd4. There are 101 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 232 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNB4NM_021629.4 linkc.186T>C p.His62His synonymous_variant Exon 4 of 10 ENST00000232564.8 NP_067642.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNB4ENST00000232564.8 linkc.186T>C p.His62His synonymous_variant Exon 4 of 10 1 NM_021629.4 ENSP00000232564.3

Frequencies

GnomAD3 genomes
AF:
0.00152
AC:
232
AN:
152234
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000313
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00276
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00171
AC:
431
AN:
251336
AF XY:
0.00185
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00387
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.00286
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.00186
AC:
2706
AN:
1452964
Hom.:
13
Cov.:
28
AF XY:
0.00194
AC XY:
1405
AN XY:
723556
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33288
American (AMR)
AF:
0.000470
AC:
21
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00468
AC:
122
AN:
26084
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39616
South Asian (SAS)
AF:
0.00110
AC:
95
AN:
86078
European-Finnish (FIN)
AF:
0.000505
AC:
27
AN:
53416
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5762
European-Non Finnish (NFE)
AF:
0.00213
AC:
2352
AN:
1103932
Other (OTH)
AF:
0.00135
AC:
81
AN:
60082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
111
222
333
444
555
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00152
AC:
232
AN:
152352
Hom.:
0
Cov.:
33
AF XY:
0.00136
AC XY:
101
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41592
American (AMR)
AF:
0.000392
AC:
6
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4824
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00276
AC:
188
AN:
68020
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00250
Hom.:
0
Bravo
AF:
0.00140
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00207
EpiControl
AF:
0.00213

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 14, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28975462) -

May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GNB4: BP4, BP7 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Charcot-Marie-Tooth disease dominant intermediate F Benign:2
Oct 09, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 26, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 11, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
1.2
DANN
Benign
0.34
PhyloP100
0.15
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149798652; hg19: chr3-179137204; COSMIC: COSV51709263; COSMIC: COSV51709263; API